first-line treatment selection in myelofibrosis
Published 2 years ago • 1.1K plays • Length 3:19Download video MP4
Download video MP3
Similar videos
-
1:30
optimal approach to first-line therapy in myelofibrosis
-
3:48
jak inhibition for the early treatment of myelofibrosis
-
1:56
incorporating novel agents for myelofibrosis in the pre- and post-transplant settings
-
4:16
jak inhibitor selection & sequencing in myelofibrosis
-
13:48
understanding treatment options for et, pv, and myelofibrosis
-
2:44
myelofibrosis: jenson shares his experience
-
4:36
being marilyn…with myelofibrosis—an mf journey
-
2:01
early myelofibrosis: current treatment approaches and novel strategies
-
1:01
latest advances in myelofibrosis treatment
-
1:25
the current approach to managing patients with prefibrotic pmf
-
1:15
exploring the evolving treatment landscape of myelofibrosis
-
2:00
novel treatment strategies in myelofibrosis
-
2:33
optimizing current treatment approaches in myelofibrosis
-
0:40
the impact of an evolving first-line setting on subsequent treatment lines in multiple myeloma
-
1:28
comorbidities and treatment decisions in myelofibrosis
-
1:52
results of phase i study of mcl-1 inhibition with azd5991 in r/r hematologic malignancies
-
1:52
the role of ruxolitinib in the treatment of early-stage myelofibrosis
-
1:31
promising agents under investigation for the treatment of myelofibrosis with cytopenia
-
1:13
the current bsh guidelines for the diagnosis and evaluation of prognosis of myelofibrosis
-
0:57
myelofibrosis treatment in 5 years
-
2:13
splicing mutations in post-et/post-pv myelofibrosis